Elite Pharmaceuticals, Inc. ELTP
0.24 USD 0.00 (+0.46%)
Nov 4, 2026, 3:46 PM EST
0.224 Day range 0.2479
0.22 52-week range 0.68
- YTD
- -50.82%
- 1 year
- -60.49%
- Market cap
- 259.59M
- EPS (ttm)
- 0.04
- P/E ratio
- 6.03
- YTD return
- -50.82%
- 1-year return
- -60.49%
- Volume
- 109.66K
- Avg volume
- 832.81K
- Open
- 0.2431
- Previous close
- 0.2399
- Day's range
- 0.224 – 0.2479
- 52-week range
- 0.22 – 0.68
YTD -0.2590 (-51.80%)
Financials — quick view
ELTP Revenue — quarterly 8.98M
ELTP Net income — quarterly 1.14M
ELTP EPS — quarterly 0.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Feb 14, 2024 | Dec 1, 2023 | 0.00 | 0.00 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | 0.00 | — | — |
News
Elite Pharmaceuticals Expands Board of Directors with Election of Aqeel A. Fatmi, Ph.D. 
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy? 
ELTP Downgraded to Neutral on Pricing Pressure & Limited Visibility 
ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy? 
Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y 
Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript 
Elite Pharmaceuticals Q1 Earnings Call Highlights 
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information 
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026 
Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL
Your note
Sign in to keep a note on ELTP — it syncs with the Stock Master app.